Taro markets a broad range of prescription and over-the-counter products in the United States. We are a leading manufacturer and supplier of topical dermatological products and also have a growing line of solid dosage form products used mainly in cardiology and neurology.
We’re proud that millions of Americans rely on our generic pharmaceuticals and over-the-counter private-label products every year. Whether you're a physician, pharmacist or patient, please consider this website your personal resource for learning more about Taro.
November 09, 2014
Taro Provides Results for September 30, 2014
November 05, 2014
Taro to Announce Second Quarter Results on November 9, 2014
August 07, 2014
Taro Provides Results for Quarter Ended June 2014
August 04, 2014
Taro to Announce Results for Quarter Ended June 30, 2014
July 08, 2014
Taro Annual Report For Fiscal Year Ended March 31, 2014 on Form 20-F Available
May 27, 2014
Taro Provides Results for Year Ended March 31, 2014